// App-Quantinova.ai

1151-237 : COMPETING RISK OF MAJOR ADVERSE CARDIAC EVENTS AND MAJOR BLEEDING IN THE ERA OF NEW ANTIPLATELET THERAPY: A META-ANALYSIS OF RANDOMIZED TRIALS

Researchers

Presenter

  • Georges El-Hayek

Principal Investigators

  • Saurav Chatterjee

  • Franz Messerli

  • Alexandre Benjo

  • Jacqueline Tamis-Holland

  • Eyal Herzog

  • Debabrata Mukherjee

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • cangrelor

  • elinogrel (IV)

  • Prasugrel

  • Vorapaxar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved